Who can deliver comprehensive medication management?
A pharmacist, in nearly every implementation. What that pharmacist may change without a new order is set by state law and by whether a collaborative practice agreement exists.
Who performs the service?
A licensed pharmacist working with the prescribing team. The clinical judgment about whether a regimen is appropriate, effective, safe and takeable is pharmacist work. Clinical staff can gather the medication history, reconcile what the patient is actually taking against what was prescribed, and support follow-up.
The more consequential question is not who performs the assessment but what they are permitted to do with the findings, and that answer changes at state lines.
What can a pharmacist change without a new prescription?
Under a collaborative practice agreement, a pharmacist may be authorized to initiate, modify or discontinue therapy within a defined protocol, order relevant laboratory monitoring, and manage titration directly. Without such an agreement, the pharmacist assesses and recommends, and every change waits on a prescriber.
Both models deliver the service. They differ in how quickly a finding becomes a change, and therefore in how much prescriber time the program consumes. A program without collaborative practice authority generates a queue of recommendations, and the queue is where value is lost: a recommendation that waits three weeks for a signature has often been overtaken by events.
Collaborative practice authority varies substantially between states, in what may be delegated, which practitioners may delegate it, whether protocols must be patient-specific, and what documentation and review cadence is required. A program design that works in one state may not transfer, and this is a question for counsel in the relevant state rather than a matter of general practice.
What can other staff contribute?
A substantial amount, and using them well is what makes the economics work. Clinical staff can collect the medication history including over-the-counter products and supplements, confirm what the patient is actually taking, identify access and cost barriers, support adherence follow-up, and coordinate with dispensing pharmacies.
That work is not incidental. The most common reason a medication assessment reaches the wrong conclusion is that it was performed against an inaccurate list. Establishing what the patient actually takes, as opposed to what the chart records, is the input the pharmacist's judgment depends on.
Where this time is captured under an existing care management program, it must be attributed to the named staff member and to the correct program, and it cannot also be counted toward another service.
Does the pharmacist need to be in the practice?
Not physically, but they do need to be in the care team. The distinction that matters is not location; it is whether the pharmacist can see the full record, reach the prescriber, and have a finding acted on. A pharmacist working remotely with chart access and a working relationship with the prescribers outperforms one on site without either.
This is the practical difference between comprehensive medication management and a review service purchased from outside the practice. An external review produces a document. An integrated pharmacist produces a changed regimen, because the loop from finding to order to monitoring closes inside one team.
Praventa delivers this with its own clinical pharmacists and separately licenses the platform to practices whose own pharmacists do the work. In both cases the design principle is the same: the assessment is only as valuable as the pathway from finding to change.
Related questions
Does CMM legally require a pharmacist?
There is no single federal rule naming who may deliver comprehensive medication management, because it is a practice standard rather than a defined benefit. In practice it rests on pharmacist clinical judgment, and payer and program requirements may specify pharmacist involvement.
What is a collaborative practice agreement?
A written arrangement under state law by which one or more prescribers delegate defined therapy management functions to a pharmacist within an agreed protocol. What may be delegated, and by whom, varies considerably between states.
Can a nurse deliver comprehensive medication management?
Nurses and other clinical staff contribute substantially, particularly to medication history, adherence support and follow-up. The comprehensive assessment of appropriateness, effectiveness and safety across a full regimen is pharmacist work.
Can the pharmacist work remotely?
Yes, provided they have full record access and a working pathway to the prescribers. Note that the pharmacist medication management CPT codes describe face-to-face services, so the reimbursement route affects the delivery mode.
Who is accountable if a recommendation is not acted on?
This should be settled explicitly in the program design. A service that ends at the recommendation leaves accountability with the prescriber; a service integrated into the care team should define who tracks open medication problems and closes them out.
Code descriptors reflect the AMA CPT code set current as of CY2026; CPT is revised annually and payer coverage varies. Scope-of-practice and collaborative practice authority are set by state law. This is a description of the service, not billing advice for a specific claim.
Talk it through with someone who runs these programs
Praventa operates care management programs with its own clinical team and licenses the same platform to practices running them in-house. Describe your situation and we will tell you which model fits.